Literature DB >> 11772392

Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.

Silvia Ginés1, Marta Mariño, Josefa Mallol, Enric I Canela, Chikao Morimoto, Christian Callebaut, Ara Hovanessian, Vicent Casadó, Carmen Lluis, Rafael Franco.   

Abstract

The extra-enzymic function of cell-surface adenosine deaminase (ADA), an enzyme mainly localized in the cytosol but also found on the cell surface of monocytes, B cells and T cells, has lately been the subject of numerous studies. Cell-surface ADA is able to transduce co-stimulatory signals in T cells via its interaction with CD26, an integral membrane protein that acts as ADA-binding protein. The aim of the present study was to explore whether ADA-CD26 interaction plays a role in the adhesion of lymphocyte cells to human epithelial cells. To meet this aim, different lymphocyte cell lines (Jurkat and CEM T) expressing endogenous, or overexpressing human, CD26 protein were tested in adhesion assays to monolayers of colon adenocarcinoma human epithelial cells, Caco-2, which express high levels of cell-surface ADA. Interestingly, the adhesion of Jurkat and CEM T cells to a monolayer of Caco-2 cells was greatly dependent on CD26. An increase by 50% in the cell-to-cell adhesion was found in cells containing higher levels of CD26. Incubation with an anti-CD26 antibody raised against the ADA-binding site or with exogenous ADA resulted in a significant reduction (50-70%) of T-cell adhesion to monolayers of epithelial cells. The role of ADA-CD26 interaction in the lymphocyte-epithelial cell adhesion appears to be mediated by CD26 molecules that are not interacting with endogenous ADA (ADA-free CD26), since SKW6.4 (B cells) that express more cell-surface ADA showed lower adhesion than T cells. Adhesion stimulated by CD26 and ADA is mediated by T cell lymphocyte function-associated antigen. A role for ADA-CD26 interaction in cell-to-cell adhesion was confirmed further in integrin activation assays. FACS analysis revealed a higher expression of activated integrins on T cell lines in the presence of increasing amounts of exogenous ADA. Taken together, these results suggest that the ADA-CD26 interaction on the cell surface has a role in lymphocyte-epithelial cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772392      PMCID: PMC1222300          DOI: 10.1042/0264-6021:3610203

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.

Authors:  N H Dang; Y Torimoto; K Sugita; J F Daley; P Schow; C Prado; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

2.  The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity.

Authors:  M Hegen; G Niedobitek; C E Klein; H Stein; B Fleischer
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

Review 3.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 4.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Activation pathways for human T-lymphocytes defined by monoclonal antibodies against T-cell surface structures.

Authors:  B Fleischer
Journal:  Arzneimittelforschung       Date:  1987-05

6.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1.

Authors:  M L Dustin; T A Springer
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

7.  Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency.

Authors:  M R Blackburn; S K Datta; R E Kellems
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

8.  Presence of adenosine deaminase on the surface of mononuclear blood cells: immunochemical localization using light and electron microscopy.

Authors:  J M Aran; D Colomer; E Matutes; J L Vives-Corrons; R Franco
Journal:  J Histochem Cytochem       Date:  1991-08       Impact factor: 2.479

9.  Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains.

Authors:  C Tiruppathi; Y Miyamoto; V Ganapathy; R A Roesel; G M Whitford; F H Leibach
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

10.  The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

Authors:  E Richard; F X Arredondo-Vega; I Santisteban; S J Kelly; D D Patel; M S Hershfield
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  15 in total

1.  Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.

Authors:  Yuko Ohara-Nemoto; Manami Nakasato; Yu Shimoyama; Tomomi T Baba; Takeshi Kobayakawa; Toshio Ono; Takashi Yaegashi; Shigenobu Kimura; Takayuki K Nemoto
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

Review 3.  Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?

Authors:  Petr Busek; Jonathan S Duke-Cohan; Aleksi Sedo
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

4.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells.

Authors:  Yuliia Kaljas; Chengqian Liu; Maksym Skaldin; Chengxiang Wu; Qing Zhou; Yuanan Lu; Ivona Aksentijevich; Andrey V Zavialov
Journal:  Cell Mol Life Sci       Date:  2016-09-23       Impact factor: 9.261

5.  The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells.

Authors:  Gennady G Yegutkin; Tiina Henttinen; Sergei S Samburski; Jozef Spychala; Sirpa Jalkanen
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

6.  Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus.

Authors:  Bagher Larijani; Ramin Heshmat; Mina Ebrahimi-Rad; Shohreh Khatami; Shirin Valadbeigi; Reza Saghiri
Journal:  Enzyme Res       Date:  2016-12-05

Review 7.  Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.

Authors:  Mieke Metzemaekers; Jo Van Damme; Anneleen Mortier; Paul Proost
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

8.  Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins.

Authors:  Estefanía Moreno; Júlia Canet; Eduard Gracia; Carme Lluís; Josefa Mallol; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

9.  Dissecting Heterosis During the Ear Inflorescence Development Stage in Maize via a Metabolomics-based Analysis.

Authors:  Xia Shi; Xuehai Zhang; Dakun Shi; Xiangge Zhang; Weihua Li; Jihua Tang
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

Review 10.  Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes.

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2015-09-29       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.